Praxis Precision Medicines Inc
NASDAQ:PRAX

Watchlist Manager
Praxis Precision Medicines Inc Logo
Praxis Precision Medicines Inc
NASDAQ:PRAX
Watchlist
Price: 76.52 USD 5.05% Market Closed
Market Cap: 1.4B USD
Have any thoughts about
Praxis Precision Medicines Inc?
Write Note

Wall Street
Price Targets

PRAX Price Targets Summary
Praxis Precision Medicines Inc

Wall Street analysts forecast PRAX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PRAX is 148.51 USD with a low forecast of 57.57 USD and a high forecast of 283.5 USD.

Lowest
Price Target
57.57 USD
25% Downside
Average
Price Target
148.51 USD
94% Upside
Highest
Price Target
283.5 USD
270% Upside

PRAX Last Price Targets
Praxis Precision Medicines Inc

The latest public price target was made on Sep 4, 2024 by Ami Fadia from Needham , who expects PRAX stock to rise by 97% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Ami Fadia
Needham
151 USD
Upside 97%
3 months ago
Sep 4, 2024
Praxis Precision Medicines Inc. (PRAX) PT Raised to $151 at Needham
StreetInsider
Douglas Tsao
H.C. Wainwright
120 USD
Upside 57%
3 months ago
Sep 4, 2024
H.C. Wainwright Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)
StreetInsider
Francois Brisebois
Oppenheimer
143 USD
Upside 87%
3 months ago
Sep 3, 2024
Praxis Precision Medicines Inc. (PRAX) PT Raised to $143 at Oppenheimer
StreetInsider
Joon Lee
Truist Financial
150 USD
Upside 96%
3 months ago
Sep 3, 2024
Truist Securities Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)
StreetInsider
Ami Fadia
Needham
145 USD
Upside 89%
4 months ago
Aug 14, 2024
These Analysts Increase Their Forecasts On Praxis Precision Medicines After Q2 Results
Benzinga
Yatin Suneja
Guggenheim
170 USD
Upside 122%
4 months ago
Aug 14, 2024
Praxis Precision price target raised to $170 from $155 at Guggenheim
TheFly
Francois Brisebois
Oppenheimer
134 USD
Upside 75%
4 months ago
Aug 5, 2024
Oppenheimer Starts Praxis Precision Medicines Inc. (PRAX) at Outperform
StreetInsider
Kambiz Yazdi
Jefferies
141 USD
Upside 84%
6 months ago
May 28, 2024
Praxis Precision Medicines Inc. (PRAX) PT Raised to $141 at Jefferies
StreetInsider
Kambiz Yazdi
Jefferies
128 USD
Upside 67%
8 months ago
Mar 26, 2024
Praxis Precision Medicines Inc. (PRAX) PT Raised to $128 at Jefferies on increases probability of success for PRAX-628 and Ulixa
StreetInsider
Show More Price Targets
Show Less Price Targets
Ami Fadia
Needham
Price Target 151 USD
Upside/Downside 97%
View Source
Douglas Tsao
H.C. Wainwright
Price Target 120 USD
Upside/Downside 57%
View Source
Francois Brisebois
Oppenheimer
Price Target 143 USD
Upside/Downside 87%
View Source
Joon Lee
Truist Financial
Price Target 150 USD
Upside/Downside 96%
View Source
Ami Fadia
Needham
Price Target 145 USD
Upside/Downside 89%
View Source
Yatin Suneja
Guggenheim
Price Target 170 USD
Upside/Downside 122%
View Source
Francois Brisebois
Oppenheimer
Price Target 134 USD
Upside/Downside 75%
View Source
Kambiz Yazdi
Jefferies
Price Target 141 USD
Upside/Downside 84%
View Source
Kambiz Yazdi
Jefferies
Price Target 128 USD
Upside/Downside 67%
View Source
Show More Price Targets
Show Less Price Targets
Praxis Precision Medicines Inc Competitors:
Price Targets
301080
Acrobiosystems Co Ltd
8% Upside
ARGX
argenx SE
3% Downside
302440
SK Bioscience Co Ltd
8% Downside
7774
Japan Tissue Engineering Co Ltd
172% Upside
IDYA
IDEAYA Biosciences Inc
118% Upside
VTGN
VistaGen Therapeutics Inc
430% Upside
PRLD
Prelude Therapeutics Inc
324% Upside
BPMC
Blueprint Medicines Corp
42% Upside

Revenue
Forecast

Revenue Estimate
Praxis Precision Medicines Inc

The compound annual growth rate of Praxis Precision Medicines Inc's revenue for the next 4 years is 159%.

N/A
Past Growth
159%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Praxis Precision Medicines Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
Praxis Precision Medicines Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-84%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PRAX's stock price target?
Price Target
148.51 USD

According to Wall Street analysts, the average 1-year price target for PRAX is 148.51 USD with a low forecast of 57.57 USD and a high forecast of 283.5 USD.

What is Praxis Precision Medicines Inc's Revenue forecast?
Projected CAGR
159%

The compound annual growth rate of Praxis Precision Medicines Inc's revenue for the next 4 years is 159%.

Back to Top